BackAequus Pharmaceuticals Overview

Aequus Pharmaceuticals Current Assets

Aequus Pharmaceuticals's current assets is $200K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$196156.00
↓ 36.03% YoYΔ $-110501.00 vs prior year quarter

Peer trimmed avg / median

Loading

Aequus Pharmaceuticals Current Assets History

Loading

Aequus Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Aequus Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aequus Pharmaceuticals (AQS.V) FAQ

As of the most recent data (September 2025), AQS.V shows a current assets of $200K. That compares with $310K in the prior-year period — down 36.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AQS.V's current assets is now $200K (was $310K) — a 36.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aequus Pharmaceuticals is outperforming or lagging.

Tracking AQS.V's current assets over time shows whether Aequus Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $200K That compares with $310K in the prior-year period — down 36.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Aequus Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $200K) with ownership activity and broader fundamentals.